Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

30 March 2009

Plasma levels of von Willebrand factor in subjects with isolated impaired fasting glucose

Erkan CobanABCDEF, Feyzi BostanABDEF

Med Sci Monit 2009; 15(4): CR194-197 :: ID: 869621

Abstract

Background
It has been shown that an increased von Willebrand factor level reflects endothelial dysfunction and may also have prognostic value in patients with atherosclerotic disease. Impaired fasting glucose is likely a frequent glycemic disorder in the general population and is considered a prediabetic state. Impaired fasting glucose is associated with cardiovascular disease, but it is unclear whether it is an independent risk factor because it commonly coexists with other cardiovascular risk factors present in metabolic syndrome. The present study was designed to evaluate the von Willebrand factor level in subjects with isolated impaired fasting glucose compared to healthy normoglycemic subjects.
Material and Method
We selected 48 subjects with isolated impaired fasting glucose and 48 normoglycemic control subjects matched for age, sex, and body mass index. We measured the von Willebrand factor level in all subjects.
Results
The von Willebrand factor level was significantly higher in the isolated impaired fasting glucose group than in the control group (111.08%+/-52.78% vs 74.08%+/-48.47%) (P=0.001). The von Willebrand factor level was also positively correlated with fasting plasma glucose in the isolated impaired fasting glucose group (P=0.004).
Conclusions
Our results show that subjects with isolated impaired fasting glucose have higher von Willebrand factor levels, which suggests endothelial dysfunction.

Keywords: von Willebrand Factor - metabolism, Fasting, Case-Control Studies, Blood Glucose - metabolism

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

Database Analysis  

Long-Term Prognosis of Patients Undergoing Percutaneous Coronary Intervention: The Impact of Serum Creatini...

Med Sci Monit In Press; DOI: 10.12659/MSM.943063  

Database Analysis  

Maternal Exposure to Environmental Air Pollution and Premature Rupture of Membranes: Evidence from Southern...

Med Sci Monit In Press; DOI: 10.12659/MSM.943601  

Animal Research  

Enhanced Bone Healing Through Systemic Capsaicin Administration: An Experimental Study on Wistar Rats

Med Sci Monit In Press; DOI: 10.12659/MSM.942485  

Clinical Research  

Differential Inflammatory Responses in Adult and Pediatric COVID-19 Patients: Implications for Long-Term Co...

Med Sci Monit In Press; DOI: 10.12659/MSM.944052  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750